Changeflow GovPing Healthcare & Life Sciences MHRA NICE Integrated Scientific Advice Service ...
Routine Guidance Amended Final

MHRA NICE Integrated Scientific Advice Service Guidance

Favicon for www.gov.uk MHRA Guidance & Safety
Published
Detected
Email

Summary

The MHRA and NICE have updated guidance on their Integrated Scientific Advice (ISA) service for medicine developers. The updates provide additional information on preparing for ISA meetings, including specific guidance on writing questions, creating briefing books, and understanding ISA reports and fees.

Published by MHRA on gov.uk . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

The Medicines and Healthcare products Regulatory Agency is the UK's medicines and medical devices regulator. MHRA publications include drug safety alerts, device field safety notices, Class 1-4 defect recalls, guidance updates, and the monthly medicines shortage list. Around 55 publications a month. Device field safety notices in particular are useful because MHRA often publishes them hours before other European regulators (ANSM, BfArM) surface the same recall. Watch this if you manufacture or distribute medicines or medical devices in the UK and EU, run a hospital pharmacy, advise on MHRA licensing, or follow post-market surveillance signals across European markets.

Notice an inaccuracy or want this record removed? Email corrections@changeflow.com . We respond within 48 hours and honor reasonable requests. See our editorial standards .

What changed

The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have updated their guidance concerning the Integrated Scientific Advice (ISA) service. This update provides supplementary information for medicine developers seeking coordinated regulatory and health technology assessment advice. Key areas covered include advice on formulating effective questions for the ISA service, preparing necessary documentation such as briefing books, understanding the fee structure, and maximizing the benefit of ISA meetings and reports.

While this update is primarily informational and does not introduce new regulatory obligations or deadlines, developers utilizing the ISA service should review the updated guidance to ensure their applications and preparations are aligned with the latest recommendations. The updated documents aim to streamline the application process and enhance the value of the scientific advice provided by the MHRA and NICE.

What to do next

  1. Review updated guidance on Integrated Scientific Advice (ISA) service application questions
  2. Consult updated briefing book template and guidance on preparing ISA documentation

Archived snapshot

Mar 17, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Guidance

Get more help to apply for medicines Integrated Scientific Advice (ISA)

Extra information for the Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care Excellence (NICE) Integrated Scientific Advice (ISA) service.

From: Medicines and Healthcare products Regulatory Agency and National Institute for Health and Care Excellence Published 20 February 2026 Last updated 16 March 2026
See all updates Get emails about this page

Documents

Writing good questions for Integrated Scientific Advice (ISA)

HTML


Creating an ISA briefing book

HTML


Find out about fees for the ISA service

HTML


Getting the most from your ISA meeting

HTML


Understanding your ISA report

HTML


All Integrated Scientific Advice (ISA) service application questions

HTML


MHRA and NICE Integrated Scientific Advice briefing book template

MS Word Document, 4.57 MB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.


Details

This service offers a coordinated approach from the the MHRA and NICE to regulatory and health technology assessment (HTA) advice for medicine developers. See specific information on:

  • good questions for the ISA service
  • documents you need to prepare
  • fees
  • presenting at an ISA meeting
  • ISA service reports

Updates to this page

Published 20 February 2026 Last updated 16 March 2026 show all updates
1.
16 March 2026

Changes made to update the document Scientific Advice (ISA) service application questions
2.
20 February 2026

First published.

Sign up for emails or print this page

Get emails about this page Print this page

Get daily alerts for MHRA Guidance & Safety

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from MHRA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
MHRA
Published
February 20th, 2026
Instrument
Guidance
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Drug manufacturers Medical device makers
Geographic scope
United Kingdom gb

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when MHRA Guidance & Safety publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!